FTH insider transactions
Faeth Therapeutics Inc. (FTH) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
FTH insiders
Everyone who has filed a Form 3, 4, 5 or 144 at Faeth Therapeutics Inc., latest first. Follow anyone to get their next filing.
- Anand Kiran ParikhPresident and CEO, Director, since February 2026+$55.4K
- Karen H VousdenDirector, since September 2026
- Khosla Ventures VI, L.P.10% owner, since June 2026
- Josiah CraverPao, since September 2024
- Brian C StephensonChief Financial Officer, since June 2026+$1.13M
- Saira RamasastryDirector, since June 2026
- Stephen M. HahnDirector, since June 2026
- Christopher GerryPresident & PEO, since November 2025
- Phillip B. DonenbergDirector, since February 2026
- Bob HolmenDirector
- Cambrian BioPharma Inc10% owner+$2.5M-$788K
- James Peyer10% owner, since February 2021+$2.51M-$788K
- Millennium Management LLC10% owner+$960K-$628K
- Thomas G RicksDirector+$250K
- Kristian HumerDirector, since July 2021
- William R RingoDirector, since March 2022
- John CelebiPresident and CEO, Director+$425
- Edward van der HorstChief Scientific Officer, since December 2022
- Stephanie KrebsChief Business Officer, since November 2023
- Jessie EnglishDirector, since April 2021
- Deneen VojtaDirector
- David G GaieroPrincipal Financial Officer, since May 2024
- Erin ColganChief Financial Officer
- Patrick Stephen GallagherOfficer, since June 2022
- Samuel BroderDirector
- Apeiron Investment Group Ltd.10% owner, since July 2022+$3,539-$5.44M
- Robert Hamilton PierceOfficer, since February 2021-$568K